BackBioLASCO Taiwan , Ltd. Overview

BioLASCO Taiwan , Ltd. Long Term Debt

BioLASCO Taiwan , Ltd.'s long-term debt is $74M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$74.01M
↓ 17.63% YoYΔ $-15.84M vs prior year quarter

Peer trimmed avg / median

Loading

BioLASCO Taiwan , Ltd. Long Term Debt History

Loading

BioLASCO Taiwan , Ltd. vs. peers: Long Term Debt Comparison

Loading

BioLASCO Taiwan , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioLASCO Taiwan , Ltd. (6662.TWO) FAQ

The latest long-term debt for 6662.TWO is $74M as of June 2026. That compares with $90M in the prior-year period — down 17.6% year over year. Investors often review this figure alongside BioLASCO Taiwan , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6662.TWO's long-term debt moved from $90M to $74M — a 17.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioLASCO Taiwan , Ltd.'s operating scale or balance-sheet position.

A long-term debt figure of $74M for 6662.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6662.TWO's long-term debt ($74M), review year-over-year change from $90M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack BioLASCO Taiwan , Ltd.'s long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.